[NK activity and T cell subsets in percutaneous ethanol injection therapy of liver cancer--effect of lentinan with combined use].
Yamamoto
S
S
Department of Medicine, Kawasaki Medical School.
Takatori
K
K
Ohmoto
K
K
Ideguchi
S
S
Yamamoto
R
R
Ohumi
T
T
Hino
K
K
Hirano
Y
Y
D000279:Administration, Cutaneous; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D000431:Ethanol / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D007912:Lentinan / Q000008:administration & dosage* / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000628:therapy*; D011134:Polysaccharides / Q000008:administration & dosage*; D013601:T-Lymphocytes / Q000145:classification*
D011134:Polysaccharides; D007912:Lentinan; D000431:Ethanol